SEC FORM 4
$181,257.78
Oric Pharmaceuticals, Inc. (ORIC)
Sale of 13,400 shares at $13.5267 per share.
Reporting Person Piscitelli Dominic · Officer Title Chief Financial Officer · Transaction Code S
Traded Sep 28, 2026 · Disclosed Sep 29, 2026
Source: SEC Form 4 · 0001695028-26-000010 · filed 2026-09-29 · View filing →